Empagliflozin, a sodium glucose cotransporter-2 inhibitor, ameliorates peritoneal fibrosis via suppressing TGF-β/Smad signaling-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Empagliflozin, a sodium glucose cotransporter-2 inhibitor, ameliorates peritoneal fibrosis via suppressing TGF-β/Smad signaling

Published:2021-04 Issue: Volume:93 Page:107374
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Shentu Yangping,Li Yuyang,Xie Shicheng,Jiang Huanchang,Sun Shicheng,Lin Rixu,Chen Chaosheng,Bai Yongheng,Zhang Yu,Zheng Chenfei,Zhou Ying

Funder

National Natural Science Foundation of China

Natural Science Foundation of Zhejiang Province

Wenzhou Municipal Science and Technology Bureau

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference38 articles.

1. Autophagy promotes fibrosis and apoptosis in the peritoneum during long-term peritoneal dialysis;Wu;J. Cell Mol. Med.,2018

2. Biocompatible peritoneal dialysis: the target is still way off;Bartosova;Front. Physiol.,2018

3. Are the mesothelial-to-mesenchymal transition, sclerotic peritonitis syndromes, and encapsulating peritoneal sclerosis part of the same process?;Loureiro;Int. J. Nephrol.,2013

4. Protein kinase C alpha inhibition prevents peritoneal damage in a mouse model of chronic peritoneal exposure to high-glucose dialysate;Wang;Kidney Int.,2016

5. SGLT-2 inhibitors reduce glucose absorption from peritoneal dialysis solution by suppressing the activity of SGLT-2;Zhou;Biomed. Pharmacother.,2019

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peritoneal fibrosis: from pathophysiological mechanism to medicine;Frontiers in Physiology;2024-09-04

2. Empagliflozin attenuates epithelial-to-mesenchymal transition through senescence in peritoneal dialysis;American Journal of Physiology-Renal Physiology;2024-09-01

3. Astragalus membranaceus and its monomers treat peritoneal fibrosis and related muscle atrophy through the AR/TGF-β1 pathway;Frontiers in Pharmacology;2024-08-22

4. Effects of Sodium–Glucose Cotransporter 2 Inhibitors in Diabetic and Non-Diabetic Patients with Advanced Chronic Kidney Disease in Peritoneal Dialysis on Residual Kidney Function: In Real-World Data;Medicina;2024-07-24

5. Coupling Osmotic Efficacy with Biocompatibility in Peritoneal Dialysis: A Stiff Challenge;International Journal of Molecular Sciences;2024-03-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3